Targeting PI3K Signaling in Cancer: A Cautionary Tale of Two AKTs

Area of Science:

• Oncology
• Molecular Biology
• Hepatology

Background:

• The PI3K-AKT pathway is frequently hyperactivated in various cancers, making AKT inhibitors promising therapeutic agents.
• AKT signaling plays a critical role in cell survival, proliferation, and metabolism, particularly in hepatocytes.

Purpose of the Study:

• To investigate the role of AKT signaling in liver cancer development and progression.
• To explore the consequences of AKT pathway ablation in hepatocytes within a liver cancer model.

Main Methods:

• Utilized a toxin-induced liver cancer model in mice.
• Genetically ablated AKT signaling specifically in hepatocytes.
• Assessed tumor incidence, progression, and metastatic spread to the lungs.

Main Results:

• Ablation of AKT signaling in hepatocytes led to the development of hepatocellular carcinoma.
• Suppression of AKT signaling enhanced the incidence and severity of lung metastases.
• Unexpectedly demonstrated a pro-tumorigenic role for AKT signaling in this specific liver cancer context.

Conclusions:

• AKT signaling is crucial for preventing hepatocellular carcinoma initiation in this model.
• Inhibition of AKT may promote metastasis in certain liver cancer contexts, warranting careful consideration.
• These findings challenge the conventional view of AKT as a universal anti-cancer target in all liver cancer scenarios.